Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity

作者：Cao, Chuangjie; Wang, Zhuo; Huang, Leilei; Bai, Lihong; Wang, Yuefeng; Liang, Yingjie; Dou, Chengyun; Wang, Liantang^*

来源：Scientific Reports, 2016, 6(1): 23419.

DOI：10.1038/srep23419

• OSTEOSARCOMA
• PHOSPHORYLATION
• ANGIOGENESIS
• APOPTOSIS
• RECEPTOR
• SARCOMA
• PATHWAY

Tumor endothelial marker 8 (TEM8) was recently suggested as a putative anti-tumor target in several types of human cancer based on its selective overexpression in tumor versus normal endothelial cells. The objective of this study was to detect the potential functions of TEM8 in osteosarcoma. Overall, TEM8 was mainly located in cytoplasm and was up-regulated in osteosarcoma compared to benign bone lesions and adjacent non tumor tissue (ANT). High TEM8 expression group had a significant lower overall survival rate than that in the low TEM8 expression group. TEM8 knock-down by siRNA or shRNA results in significant reduction of osteosarcoma cell growth and proliferation both in vitro and in vivo. Ablation of TEM8 led to increasing of p21 and p27 and suppression of cyclin D1 mediated by Erk1/2 activity. These findings suggest that down-regulation of TEM8 play an important role in the inhibition of tumorigenesis and development of osteosarcoma.

• 出版日期2016-3-21
• 单位山东大学; 中山大学